Amerigen, Viwa enter JV to manufacture, sell branded generic drugs in China
The products are likely to be manufactured at Amerigen’s SFDA and US FDA approved finished dose plant in Suzhou, China, on receiving approval. The marketing and sales of
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.